KCT0000454尚未招募未知
Multicenter Phase II study of Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma =5 cm
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Male or female patients =18 years of age
- •2. Intitially diagnosed or recurrent hepatocellular carcinoma (HCC)
- •3. Unresectable HCC
- •4. Cirrhotic status of Child Pugh class A or B7
- •5. Eastern Cooerative Oncology Group performance status 0 or 1
- •6. single or sum of multiple tumor =5 cm
- •7. HCC with 3 cm apart from gastrointestinal tract
- •8. The volume of uninvolved must be at least 1000 ml
- •9. Incomplete response after trans-arterial chemo-embolization of 1-5
- •10. A single lesion or multiple lesions including portal vein tumor thrombosis included in radiation field with one or consecutive sesseions of SBRT
- •11. No evidence of an uncontrolled lesion at any other site
- •12. No evidence of complications of liver cirrhosis
- •13. No evidence of uncontrolled inter-current illness
- •14. Patient or gaurdian must be able to provide verbal and written informed consent
排除标准
- •1. Patient with previous history of abdominal radiation
- •2. Direc invasion to esophagus, stomach or colon by HCC
研究者
相似试验
招募中
3 期
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10)NL-OMON52850ondon Health Sciences Center- Lawson Health Research Institute20
招募中
不适用
A phase 2 study of stereotactic ablative radiotherapy(SBRT) followed by Atezolizumab / Tiragolumab in treatment-naive patients with metastatic non-small cell lung cancerKCT0006529Yonsei University Health System, Severance Hospital45
终止
2 期
Study to assess the neurological and cognitive effects of using Hypofractionated Stereotactic Radiotherapy used to treat multiple (3-10) brain metastases.eurocognitive impairmentNeurocognitive impairmentCancer - Any cancerCancer - BrainACTRN12615001202550Icon Cancer Foundation30
招募中
不适用
Phase II multicenter study of Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaNeoplasmsKCT0000422Korea Institute of Radiological & Medical Sciences71
Unknown
2 期
The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal CancerColorectal CancerNCT04535024Fudan University60